Higher levels indicate slowed COMT activity (methylation) and are associated with a higher risk for breast cancer in females. Due to the lack of research in this area, it may be postulated that men carry a similar risk. Elevation may also be due to an overactive CYP1B1 enzyme or sluggish CYP1A1 or CYP34A. Additional support for the COMT enzyme can help with the conversion toward the inactive
metabolite, 4-M-E1.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.